The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: A report of the German study group on mycophenolate mofetil therapy

Journal of the American Society of Nephrology

Volumn 13, Issue 3, 2002, Pages 759-768

  Weber, Lutz T ^a   Shipkova, Maria ^a   Armstrong, Victor W ^a   Wagner, Natalie ^a   Schütz, Ekkehard ^a   Mehls, Otto ^a   Zimmerhackl, Lothar B ^a   Oellerich, Michael ^a   Tönshoff, Burkhard ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLUCURONIDE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYCOPHENOLIC ACID BETA D GLUCURONIDE; PREDNISONE; UNCLASSIFIED DRUG;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BODY SURFACE; CANDIDIASIS; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIARRHEA; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; GERMANY; GRAFT REJECTION; HERPES LABIALIS; HERPES ZOSTER; HUMAN; INFECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPTICEMIA; ULTRAFILTRATION; URINARY TRACT INFECTION; VIRUS INFECTION;

EID: 0036191888     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The use of mycophenolate mofetil in transplant recipients
2. Trends in immunosuppressive therapy: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
3. Pharmacokinetics of mycophenolate mofetil (RS 61443). A short review
4. Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics
5. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients
6. Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil
7. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil
8. Therapeutic monitoring of mycophenolic acid. A consensus panel report
9. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation
10. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation
11. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: A longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients
12. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: Results after 12 months of treatment
13. Mycophenolate mofetil (MMF) in pediatric renal transplantation
14. A formula to estimate the approximate surface area if height and weight be known
15. Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure
16. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
17. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
18. The effect of renal insufficiency on mycophenolic acid protein binding
19. Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients
20. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation
21. Successful mycophenolate mofetil treatment of glomerular disease
22. Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure
23. Pharmacokinetic and trough concentrations help optimize mycophenolate dosing in kidney transplant patients
24. Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable
25. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function
26. The effect of renal insufficiency on mycophenolic acid protein binding
27. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients
28. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantaiion in Japanese patients. RS-61443 Investigation Committee-Japan